<author><surname>Cryer</surname> <given-names>PE</given-names> </author><title>The barrier of hypoglycemia in diabetes</title><source>Diabetes</source><year>2008</year><volume>57</volume><fpage>3169</fpage><lpage>3176</lpage>
<author><surname>Dagogo-Jack</surname> <given-names>SE</given-names> </author><author><surname>Craft</surname> <given-names>S</given-names> </author><author><surname>Cryer</surname> <given-names>PE</given-names> </author><title>Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia</title><source>J Clin Invest</source><year>1993</year><volume>91</volume><fpage>819</fpage><lpage>828</lpage>
<author><surname>Cryer</surname> <given-names>PE</given-names> </author><title>Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes</title><source>Diabetologia</source><year>2002</year><volume>45</volume><fpage>937</fpage><lpage>948</lpage>
<author><surname>Davis</surname> <given-names>MR</given-names> </author><author><surname>Shamoon</surname> <given-names>H</given-names> </author><title>Counterregulatory adaptation to recurrent hypoglycemia in normal humans</title><source>J Clin Endocrinol Metab</source><year>1991</year><volume>73</volume><fpage>995</fpage><lpage>1001</lpage>
<author><surname>Davis</surname> <given-names>SN</given-names> </author><author><surname>Mann</surname> <given-names>S</given-names> </author><author><surname>Galassetti</surname> <given-names>P</given-names> </author><title>Effects of differing durations of antecedent hypoglycemia on counterregulatory responses to subsequent hypoglycemia in normal humans</title><source>Diabetes</source><year>2000</year><volume>49</volume><fpage>1897</fpage><lpage>1903</lpage>
<author><surname>Heller</surname> <given-names>SR</given-names> </author><author><surname>Cryer</surname> <given-names>PE</given-names> </author><title>Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans</title><source>Diabetes</source><year>1991</year><volume>40</volume><fpage>223</fpage><lpage>226</lpage>
<author><surname>Geddes</surname> <given-names>J</given-names> </author><author><surname>Wright</surname> <given-names>RJ</given-names> </author><author><surname>Zammitt</surname> <given-names>NN</given-names> </author><author><surname>Deary</surname> <given-names>IJ</given-names> </author><author><surname>Frier</surname> <given-names>BM</given-names> </author><title>An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes</title><source>Diab Care</source><year>2007</year><volume>30</volume><fpage>1868</fpage><lpage>1870</lpage>
<author><surname>Pedersen-Bjergaard</surname> <given-names>U</given-names> </author><author><surname>Agerholm-Larsen</surname> <given-names>B</given-names> </author><author><surname>Pramming</surname> <given-names>S</given-names> </author><author><surname>Hougaard</surname> <given-names>P</given-names> </author><author><surname>Thorsteinsson</surname> <given-names>B</given-names> </author><title>Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus</title><source>Lancet</source><year>2001</year><volume>357</volume><fpage>1248</fpage><lpage>1253</lpage>
<author><surname>Pedersen-Bjergaard</surname> <given-names>U</given-names> </author><author><surname>Dhamrait</surname> <given-names>SS</given-names> </author><author><surname>Sethi</surname> <given-names>AA</given-names> </author><title>Genetic variation and activity of the renin&#8211;angiotensin system and severe hypoglycemia in type 1 diabetes</title><source>Am J Med</source><year>2008</year><volume>121</volume><fpage>246</fpage><lpage>248</lpage>
<author><surname>Schouwenberg</surname> <given-names>BJ</given-names> </author><author><surname>Veldman</surname> <given-names>BA</given-names> </author><author><surname>Spiering</surname> <given-names>W</given-names> </author><title>The Arg16Gly variant of the beta2-adrenergic receptor predisposes to hypoglycemia unawareness in type 1 diabetes mellitus</title><source>Pharmacogenet Genomics</source><year>2008</year><volume>18</volume><fpage>369</fpage><lpage>372</lpage>
<author><surname>Leineweber</surname> <given-names>K</given-names> </author><author><surname>Brodde</surname> <given-names>OE</given-names> </author><title>Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes</title><source>Life Sci</source><year>2004</year><volume>74</volume><fpage>2803</fpage><lpage>2814</lpage>
<author><surname>Green</surname> <given-names>SA</given-names> </author><author><surname>Turki</surname> <given-names>J</given-names> </author><author><surname>Innis</surname> <given-names>M</given-names> </author><author><surname>Liggett</surname> <given-names>SB</given-names> </author><title>Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties</title><source>Biochemistry</source><year>1994</year><volume>33</volume><fpage>9414</fpage><lpage>9419</lpage>
<author><surname>Liggett</surname> <given-names>SB</given-names> </author><title>beta(2)-adrenergic receptor pharmacogenetics</title><source>Am J Respir Crit Care Med</source><year>2000</year><volume>161</volume><fpage>S197</fpage><lpage>S201</lpage>
<author><surname>Korytkowski</surname> <given-names>MT</given-names> </author><author><surname>Mokan</surname> <given-names>M</given-names> </author><author><surname>Veneman</surname> <given-names>TF</given-names> </author><author><surname>Mitrakou</surname> <given-names>A</given-names> </author><author><surname>Cryer</surname> <given-names>PE</given-names> </author><author><surname>Gerich</surname> <given-names>JE</given-names> </author><title>Reduced beta-adrenergic sensitivity in patients with type 1 diabetes and hypoglycemia unawareness</title><source>Diab Care</source><year>1998</year><volume>21</volume><fpage>1939</fpage><lpage>1943</lpage>
<author><surname>Fritsche</surname> <given-names>A</given-names> </author><author><surname>Stumvoll</surname> <given-names>M</given-names> </author><author><surname>Grub</surname> <given-names>M</given-names> </author><title>Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects</title><source>Diab Care</source><year>1998</year><volume>21</volume><fpage>1505</fpage><lpage>1510</lpage>
<author><surname>Berlin</surname> <given-names>I</given-names> </author><author><surname>Grimaldi</surname> <given-names>A</given-names> </author><author><surname>Payan</surname> <given-names>C</given-names> </author><title>Hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients</title><source>Diab Care</source><year>1987</year><volume>10</volume><fpage>742</fpage><lpage>747</lpage>
<author><surname>Berlin</surname> <given-names>I</given-names> </author><author><surname>Grimaldi</surname> <given-names>A</given-names> </author><author><surname>Bosquet</surname> <given-names>F</given-names> </author><author><surname>Puech</surname> <given-names>AJ</given-names> </author><title>Decreased beta-adrenergic sensitivity in insulin-dependent diabetic subjects</title><source>J Clin Endocrinol Metab</source><year>1986</year><volume>63</volume><fpage>262</fpage><lpage>265</lpage>
<author><surname>Trovik</surname> <given-names>TS</given-names> </author><author><surname>Jaeger</surname> <given-names>R</given-names> </author><author><surname>Jorde</surname> <given-names>R</given-names> </author><author><surname>Sager</surname> <given-names>G</given-names> </author><title>Reduced sensitivity to beta-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycaemia unawareness</title><source>Br J Clin Pharmacol</source><year>1994</year><volume>38</volume><fpage>427</fpage><lpage>432</lpage>
<author><surname>Schwab</surname> <given-names>KO</given-names> </author><author><surname>Menche</surname> <given-names>U</given-names> </author><author><surname>Schmeisl</surname> <given-names>G</given-names> </author><author><surname>Lohse</surname> <given-names>MJ</given-names> </author><title>Hypoglycemia-dependent beta2-adrenoceptor downregulation: a contributing factor to hypoglycemia unawareness in patients with type-1 diabetes?</title><source>Horm Res</source><year>2004</year><volume>62</volume><fpage>137</fpage><lpage>141</lpage>
<author><surname>Trovik</surname> <given-names>TS</given-names> </author><author><surname>Vaartun</surname> <given-names>A</given-names> </author><author><surname>Jorde</surname> <given-names>R</given-names> </author><author><surname>Sager</surname> <given-names>G</given-names> </author><title>Dysfunction in the beta 2-adrenergic signal pathway in patients with insulin dependent diabetes mellitus (IDDM) and unawareness of hypoglycaemia</title><source>Eur J Clin Pharmacol</source><year>1995</year><volume>48</volume><fpage>327</fpage><lpage>332</lpage>
<author><surname>Trovik</surname> <given-names>TS</given-names> </author><author><surname>Jaeger</surname> <given-names>R</given-names> </author><author><surname>Jorde</surname> <given-names>R</given-names> </author><author><surname>Sager</surname> <given-names>G</given-names> </author><title>Reduced beta-adrenergic sensitivity in healthy participants induced by hypoglycemia</title><source>Fundam Clin Pharmacol</source><year>1995</year><volume>9</volume><fpage>181</fpage><lpage>186</lpage>
<author><surname>Liu</surname> <given-names>D</given-names> </author><author><surname>Moberg</surname> <given-names>E</given-names> </author><author><surname>Kollind</surname> <given-names>M</given-names> </author><author><surname>Lins</surname> <given-names>PE</given-names> </author><author><surname>Adamson</surname> <given-names>U</given-names> </author><author><surname>MacDonald</surname> <given-names>IA</given-names> </author><title>Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia</title><source>Diabetologia</source><year>1992</year><volume>35</volume><fpage>287</fpage><lpage>290</lpage>
<author><surname>Deary</surname> <given-names>IJ</given-names> </author><author><surname>Hepburn</surname> <given-names>DA</given-names> </author><author><surname>MacLeod</surname> <given-names>KM</given-names> </author><author><surname>Frier</surname> <given-names>BM</given-names> </author><title>Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis</title><source>Diabetologia</source><year>1993</year><volume>36</volume><fpage>771</fpage><lpage>777</lpage>
<author><surname>Galan</surname> <given-names>BE</given-names> </author><author><surname>Mol</surname> <given-names>P</given-names> </author><author><surname>Wennekes</surname> <given-names>L</given-names> </author><author><surname>Schouwenberg</surname> <given-names>BJ</given-names> </author><author><surname>Smits</surname> <given-names>P</given-names> </author><title>Preserved sensitivity to beta2-adrenergic receptor agonists in patients with type 1 diabetes mellitus and hypoglycemia unawareness</title><source>J Clin Endocrinol Metab</source><year>2006</year><volume>91</volume><fpage>2878</fpage><lpage>2881</lpage>
<author><surname>Meijer</surname> <given-names>P</given-names> </author><author><surname>Wouters</surname> <given-names>CW</given-names> </author><author><surname>Broek</surname> <given-names>PH</given-names> </author><title>Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation</title><source>Br J Pharmacol</source><year>2008</year><volume>153</volume><fpage>1169</fpage><lpage>1176</lpage>
<author><surname>Lenders</surname> <given-names>J</given-names> </author><author><surname>Janssen</surname> <given-names>GJ</given-names> </author><author><surname>Smits</surname> <given-names>P</given-names> </author><author><surname>Thien</surname> <given-names>T</given-names> </author><title>Role of the wrist cuff in forearm plethysmography</title><source>Clin Sci (Lond)</source><year>1991</year><volume>80</volume><fpage>413</fpage><lpage>417</lpage>
<author><surname>Cleaveland</surname> <given-names>CR</given-names> </author><author><surname>Rangno</surname> <given-names>RE</given-names> </author><author><surname>Shand</surname> <given-names>DG</given-names> </author><title>A standardized isoproteranol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol</title><source>Arch Intern Med</source><year>1972</year><volume>130</volume><fpage>47</fpage><lpage>52</lpage>
<author><surname>Miller</surname> <given-names>SA</given-names> </author><author><surname>Dykes</surname> <given-names>DD</given-names> </author><author><surname>Polesky</surname> <given-names>HF</given-names> </author><title>A simple salting out procedure for extracting DNA from human nucleated cells</title><source>Nucleic Acids Res</source><year>1988</year><volume>16</volume><fpage>1215</fpage>
<author><surname>Ronaghi</surname> <given-names>M</given-names> </author><title>Pyrosequencing for SNP genotyping</title><source>Methods Mol Biol</source><year>2003</year><volume>212</volume><fpage>189</fpage><lpage>195</lpage>
<author><surname>Willemsen</surname> <given-names>JJ</given-names> </author><author><surname>Ross</surname> <given-names>HA</given-names> </author><author><surname>Jacobs</surname> <given-names>MC</given-names> </author><title>Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans</title><source>Clin Chem</source><year>1995</year><volume>41</volume><fpage>1455</fpage><lpage>1460</lpage>
<author><surname>Galan</surname> <given-names>BE</given-names> </author><author><surname>Tack</surname> <given-names>CJ</given-names> </author><author><surname>Lenders</surname> <given-names>JW</given-names> </author><title>Theophylline improves hypoglycemia unawareness in type 1 diabetes</title><source>Diabetes</source><year>2002</year><volume>51</volume><fpage>790</fpage><lpage>796</lpage>
<author><surname>Berlin</surname> <given-names>I</given-names> </author><author><surname>Grimaldi</surname> <given-names>A</given-names> </author><author><surname>Landault</surname> <given-names>C</given-names> </author><title>Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients</title><source>J Clin Endocrinol Metab</source><year>1988</year><volume>66</volume><fpage>273</fpage><lpage>278</lpage>